Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study.
Plomp L, Chassepot H, Psimaras D, Maisonobe T, Mensi E, Leonard-Louis S, Plu I, Rozes A, Tubach F, Touat M, Anquetil C, Wesner N, Champtiaux N, Rigolet A, Demeret S, Weiss N, Alyanakian MA, Le Panse R, Truffault F, Dragon-Durey MA, Chatenoud L, Abbar B, Bretagne MC, Procureur A, Similowski T, Morelot-Panzini C, Dres M, Ederhy S, Benveniste O, Salem JE, Allenbach Y.
Plomp L, et al. Among authors: weiss n.
Lancet Reg Health Eur. 2025 Jan 14;50:101192. doi: 10.1016/j.lanepe.2024.101192. eCollection 2025 Mar.
Lancet Reg Health Eur. 2025.
PMID: 39896961
Free PMC article.